Cargando…
Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3
Interleukin-6 (IL-6)-type cytokines share the common receptor glycoprotein 130 (gp130), which activates a signaling cascade involving Janus kinases (JAKs) and signal transducer and activator of transcription (STAT) transcription factors. IL-6 and/or its signaling pathway is often deregulated in dise...
Autores principales: | Servais, Florence A., Kirchmeyer, Mélanie, Hamdorf, Matthias, Minoungou, Nadège W.E., Rose-John, Stefan, Kreis, Stephanie, Haan, Claude, Behrmann, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479786/ https://www.ncbi.nlm.nih.gov/pubmed/31026677 http://dx.doi.org/10.1016/j.omtn.2019.03.007 |
Ejemplares similares
-
Narrative-based computational modelling of the Gp130/JAK/STAT signalling pathway
por: Guerriero, Maria Luisa, et al.
Publicado: (2009) -
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
por: Zanders, Lukas, et al.
Publicado: (2021) -
Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis
por: Bao, Jiayu, et al.
Publicado: (2023) -
JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms
por: Gäbler, Karoline, et al.
Publicado: (2013) -
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3
(
I148M
) risk allele
por: Kirchmeyer, Mélanie, et al.
Publicado: (2023)